T. Rowe Price Associates’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $291K | Sell |
|
|||||
|
2025
Q3 | $392K | Buy |
|
|||||
|
2025
Q2 | $132K | Buy |
|
|||||
|
2025
Q1 | $86K | Sell |
|
|||||
|
2024
Q4 | $148K | Sell |
|
|||||
|
2024
Q3 | $331K | Buy |
|
|||||
|
2024
Q2 | $631K | Buy |
|
|||||
|
2024
Q1 | $764K | Buy |
|
|||||
|
2023
Q4 | $458K | Buy |
|
|||||
|
2023
Q3 | $274K | Buy |
|
|||||
|
2023
Q2 | $342K | Buy |
|
|||||
|
2023
Q1 | $316K | Buy |
|
|||||
|
2022
Q4 | $386K | Sell |
|
|||||
|
2022
Q3 | $146K | Buy |
|
|||||
|
2022
Q2 | $110K | Buy |
|
|||||
|
2022
Q1 | $172K | Buy |
|
|||||
|
2021
Q4 | $234K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $12.1M | Sell |
|
|||||
|
2020
Q4 | $14.2M | Buy |
|